ASB16 and hepatocellular carcinoma: We comprehensively identified the relationship between ASB16-AS1 expression and cancer development/patient prognosis in 33 cancer types, and it was verified that ASB16-AS1 promoted the proliferation and invasion in hepatocellular carcinoma (LIHC) through related assays.